SETDB1 and breast carcinoma: MiR-7 can downregulate SET domain bifurcated 1 (SETDB1), an oncogene that is overexpressed in breast cancer, resulting in the inhibition of tumor progression and metastasis in mice, accompanied by a decrease in the BCSC subset in tumor tissues, as in our previous report [6].